| abstract |
The present invention relates to compounds of formula (I) and their pharmaceutically acceptable salts, to methods for their preparation, to intermediate compounds used to obtain them, and to compositions containing these compounds; and the use of these compounds in a method of treating a disease or condition selected from the group consisting of disorders of the central nervous system, cognitive impairment, schizophrenia, dementia and other disorders in a mammal. |